SUMOylation negatively regulates the stability of CHFR tumor suppressor.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2013-01-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2012.10.111PMID 23131550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitin-like proteins.

  2012cited by this paper
• The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition

  2010cited by this paper
• Chfr is linked to tumour metastasis through the downregulation of HDAC1

  2009cited by this paper
• Nuclear localization of Chfr is crucial for its checkpoint function

  2009cited by this paper
• Cell biology: SUMO

  2008cited by this paper
• Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity.

  2007cited by this paper
• SUMO-specific proteases: a twist in the tail.

  2007cited by this paper
• Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

  2007cited by this paper
• Concepts in sumoylation: a decade on

  2007cited by this paper
• SUMO: a history of modification.

  2005cited by this paper
• Chfr is required for tumor suppression and Aurora A regulation

  2005cited by this paper
• PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein

  2004cited by this paper
• Protein modification by SUMO.

  2004cited by this paper
• Epigenetic inactivation of CHFR in human tumors

  2003cited by this paper
• Nuclear and unclear functions of SUMO

  2003cited by this paper
• Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity.

  2002cited by this paper
• The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition

  2002cited by this paper
• Chfr defines a mitotic stress checkpoint that delays entry into metaphase

  2000cited by this paper
• SUMO-1 Modification and Its Role in Targeting the Ran GTPase-activating Protein, RanGAP1, to the Nuclear Pore Complex

  1998cited by this paper
• A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex

  1996cited by this paper

• CHFR promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a HDAC1-dependent manner

  2019cites this paper
• chFr promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a hDac1-dependent manner

  2019cites this paper
• USP7/HAUSP: A SUMO deubiquitinase at the heart of DNA replication

  2016influential citation
• Role of SIRT6 in Chromatin

  2015cites this paper
• Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets

  2014cites this paper
• CHFR is negatively regulated by SUMOylation-mediated ubiquitylation.

  2013cites this paper